CATX
Perspective Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$5.00
-0.11 ▼ -2.15%
🌙 3월 13일 7:51 PM ET (한국 3/14 08:51)
$5.00
+0.00 -0.02%
| Index | RUT | P/E | - | EPS (ttm) | -1.46 | Insider Own | 18.77% | Shs Outstand | 0.11B | Perf Week | 0.6% |
| Market Cap | 0.57B | Forward P/E | - | EPS next Y | 1.95% | Insider Trans | 0.1% | Shs Float | 0.09B | Perf Month | 2.46% |
| Enterprise Value | 0.40B | PEG | - | EPS next Q | -0.35 | Inst Own | 56.17% | Short Float | 10.42% | Perf Quarter | 96.08% |
| Income | -0.11B | P/S | 532.31 | EPS this Y | 0.43% | Inst Trans | -4.99% | Short Ratio | 2.83 | Perf Half Y | 47.93% |
| Sales | 0.00B | P/B | 1.53 | EPS next 5Y | 1.01% | ROA | -30.98% | Short Interest | 9.64M | Perf YTD | 81.82% |
| Book/sh | 3.26 | P/C | 3.27 | EPS past 3/5Y | -55.62% -9.86% | ROE | -37.24% | 52W High | -18.83% ($6.16) | Perf Year | 90.84% |
| Cash/sh | 1.53 | P/FCF | - | Sales past 3/5Y | -47.51% -27.61% | ROIC | -43.22% | 52W Low | 212.5% ($1.60) | Perf 3Y | 11.11% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -57.13% | Gross Margin | -174.33% | Volatility(W/M) | 7.49% 8.3% | Perf 5Y | -60.32% |
| Dividend TTM | - | EV/Sales | 372.65 | Sales Y/Y TTM | - | Oper. Margin | -8802.51% | ATR (14) | 0.44 | Perf 10Y | -45.65% |
| Dividend Ex-Date | - | Quick Ratio | 8.66 | EPS Q/Q | -63.24% | Profit Margin | -9841.86% | RSI (14) | 52.04 | Recom | 1.13 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.66 | Sales Q/Q | -43.36% | SMA20 | -4.44% ($5.23) | Beta | 1.8 | Target Price | $13.33 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | 20.75% ($4.14) | Rel Volume | 0.32 | Prev Close | $5.11 |
| Employees | 140 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -9.03% -14.48% | SMA200 | 43.67% ($3.48) | Avg Volume(3M) | 3.41M | Price | $5 |
| IPO | 2005/11/10 | Option/Short | Yes/Yes | Trades | 11868 | Volume | 1,089,476 | Change | -2.15% |
뉴스 로딩 중...